SCIENCE Financial Statements From 2010 to 2024
| 8D9 Stock | EUR 0.30 0.01 3.45% |
Check SCIENCE IN financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among SCIENCE IN's main balance sheet or income statement drivers, such as , as well as many indicators such as . SCIENCE financial statements analysis is a perfect complement when working with SCIENCE IN Valuation or Volatility modules.
SCIENCE |
SCIENCE IN SPORT Company Shares Outstanding Analysis
SCIENCE IN's Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
Current SCIENCE IN Shares Outstanding | 172.42 M |
Most of SCIENCE IN's fundamental indicators, such as Shares Outstanding, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, SCIENCE IN SPORT is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
| Competition |
Based on the latest financial disclosure, SCIENCE IN SPORT has 172.42 M of shares currently outstending. This is 58.59% lower than that of the Consumer Defensive sector and 33.47% lower than that of the Packaged Foods industry. The shares outstanding for all Germany stocks is 69.85% higher than that of the company.
SCIENCE IN SPORT Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining SCIENCE IN's current stock value. Our valuation model uses many indicators to compare SCIENCE IN value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across SCIENCE IN competition to find correlations between indicators driving SCIENCE IN's intrinsic value. More Info.SCIENCE IN SPORT is rated fifth in return on equity category among its peers. It also is rated fifth in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the SCIENCE IN's earnings, one of the primary drivers of an investment's value.About SCIENCE IN Financial Statements
SCIENCE IN stakeholders use historical fundamental indicators, such as SCIENCE IN's revenue or net income, to determine how well the company is positioned to perform in the future. Although SCIENCE IN investors may analyze each financial statement separately, they are all interrelated. For example, changes in SCIENCE IN's assets and liabilities are reflected in the revenues and expenses on SCIENCE IN's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in SCIENCE IN SPORT. Please read more on our technical analysis and fundamental analysis pages.
Science in Sport plc, together with its subsidiaries, develops, manufactures, and markets sports nutrition products for professional athletes, and sports and fitness enthusiasts. Science in Sport plc was founded in 1992 and is headquartered in London, the United Kingdom. SCIENCE IN is traded on Frankfurt Stock Exchange in Germany.
Currently Active Assets on Macroaxis
Other Information on Investing in SCIENCE Stock
SCIENCE IN financial ratios help investors to determine whether SCIENCE Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in SCIENCE with respect to the benefits of owning SCIENCE IN security.